United Arab Emirates · Delayed Price · Currency is AED Pure Health Holding PJSC Statistics
Total Valuation
ADX:PUREHEALTH has a market cap or net worth of AED 24.44 billion. The enterprise value is 37.87 billion.
| Market Cap | 24.44B |
| Enterprise Value | 37.87B |
Important Dates
The next estimated earnings date is Friday, July 31, 2026.
| Earnings Date | Jul 31, 2026 |
| Ex-Dividend Date | Apr 10, 2026 |
Share Statistics
ADX:PUREHEALTH has 11.11 billion shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | 11.11B |
| Shares Outstanding | 11.11B |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 0.23% |
| Owned by Institutions (%) | 0.23% |
| Float | 2.48B |
Valuation Ratios
The trailing PE ratio is 12.97 and the forward PE ratio is 15.19. ADX:PUREHEALTH's PEG ratio is 1.48.
| PE Ratio | 12.97 |
| Forward PE | 15.19 |
| PS Ratio | 0.87 |
| PB Ratio | 1.32 |
| P/TBV Ratio | 4.00 |
| P/FCF Ratio | 6.76 |
| P/OCF Ratio | 5.29 |
| PEG Ratio | 1.48 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.63, with an EV/FCF ratio of 10.47.
| EV / Earnings | 20.09 |
| EV / Sales | 1.35 |
| EV / EBITDA | 8.63 |
| EV / EBIT | 14.66 |
| EV / FCF | 10.47 |
Financial Position
The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.98.
| Current Ratio | 1.27 |
| Quick Ratio | 1.08 |
| Debt / Equity | 0.98 |
| Debt / EBITDA | 4.14 |
| Debt / FCF | 5.02 |
| Interest Coverage | 2.96 |
Financial Efficiency
Return on equity (ROE) is 10.02% and return on invested capital (ROIC) is 7.67%.
| Return on Equity (ROE) | 10.02% |
| Return on Assets (ROA) | 3.07% |
| Return on Invested Capital (ROIC) | 7.67% |
| Return on Capital Employed (ROCE) | 6.26% |
| Weighted Average Cost of Capital (WACC) | 6.76% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.53 |
| Inventory Turnover | 14.53 |
Taxes
In the past 12 months, ADX:PUREHEALTH has paid 208.57 million in taxes.
| Income Tax | 208.57M |
| Effective Tax Rate | 9.75% |
Stock Price Statistics
The stock price has decreased by -17.91% in the last 52 weeks. The beta is 0.78, so ADX:PUREHEALTH's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | -17.91% |
| 50-Day Moving Average | 2.14 |
| 200-Day Moving Average | 2.54 |
| Relative Strength Index (RSI) | 57.64 |
| Average Volume (20 Days) | 1,591,164 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ADX:PUREHEALTH had revenue of AED 27.99 billion and earned 1.88 billion in profits. Earnings per share was 0.17.
| Revenue | 27.99B |
| Gross Profit | 6.66B |
| Operating Income | 2.58B |
| Pretax Income | 2.14B |
| Net Income | 1.88B |
| EBITDA | 3.50B |
| EBIT | 2.58B |
| Earnings Per Share (EPS) | 0.17 |
Balance Sheet
The company has 4.75 billion in cash and 18.15 billion in debt, with a net cash position of -13.40 billion or -1.21 per share.
| Cash & Cash Equivalents | 4.75B |
| Total Debt | 18.15B |
| Net Cash | -13.40B |
| Net Cash Per Share | -1.21 |
| Equity (Book Value) | 18.52B |
| Book Value Per Share | 1.66 |
| Working Capital | 4.30B |
Cash Flow
In the last 12 months, operating cash flow was 4.62 billion and capital expenditures -1.01 billion, giving a free cash flow of 3.62 billion.
| Operating Cash Flow | 4.62B |
| Capital Expenditures | -1.01B |
| Depreciation & Amortization | 914.58M |
| Net Borrowing | -764.40M |
| Free Cash Flow | 3.62B |
| FCF Per Share | 0.33 |
Margins
Gross margin is 23.80%, with operating and profit margins of 9.23% and 6.73%.
| Gross Margin | 23.80% |
| Operating Margin | 9.23% |
| Pretax Margin | 7.64% |
| Profit Margin | 6.73% |
| EBITDA Margin | 12.50% |
| EBIT Margin | 9.23% |
| FCF Margin | 12.92% |
Dividends & Yields
This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 2.60%.
| Dividend Per Share | 0.05 |
| Dividend Yield | 2.60% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 18.59% |
| Buyback Yield | 0.00% |
| Shareholder Yield | 2.60% |
| Earnings Yield | 7.71% |
| FCF Yield | 14.80% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for ADX:PUREHEALTH is 3.78, which is 71.82% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 3.78 |
| Price Target Difference | 71.82% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 10.51% |
| EPS Growth Forecast (3Y) | 13.09% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ADX:PUREHEALTH has an Altman Z-Score of 1.34 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.34 |
| Piotroski F-Score | 4 |